… of sentinel lymph node biopsy for early-stage breast cancer, … rates of intraoperative sentinel
lymph node identification and of … being investigated and in lymphatic mapping techniques. …

… lymphatic mapping and sentinel lymph node biopsy (SLNB) were described for breast cancers
… than ALND for staging clinically node-negative (cN0) breast cancers. Long-term follow-up …

… breast cancer … lymph node dissection (ALND) are known to be significant risk factors for
development of lymphedema and reduced ROM. While the introduction of sentinel lymph node …

… In coclusion, while the benefit of axillary lymph node dissection in early stage breast cancer
is discussed3, we think that patients with low risk of recurrence can be better identified with …

… of sentinel lymph node (SLN) surgery for staging of node-negative breast cancer to clinical
… trial leading to avoiding axillary lymph node dissection (ALND) for patients undergoing …

… with T1–2 breast cancer and one to two sentinel lymph node macrometastases undergoing
… (axillary lymph node dissection) or experimental treatment (sentinel lymph node biopsy only). …

… this tool in the sentinel lymph nodes positivity prediction for … of patients affected by breast
cancer referred to our institute. … it to the task to predict sentinel lymph nodes status in clinically …

… dissection (ALND) in patients undergoing either breast-conserving surgery or mastectomy
for T1–2 breast cancer (BC) and presenting one or two macrometastatic sentinel lymph nodes …

… we considered the brightest lymph node to be the sentinel lymph node in this study. In most
cases, it was an obvious bright light that was emitted by the ICG-positive lymph node. In such …

… Breast cancer patients with positive sentinel lymph node (SLN) but a low risk of non-sentinel
lymph node (NSLN) metastasis should be exempted from axillary lymph node dissection (…